CGL
Clarius Group LLC’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $407K | Buy |
19,257
+26
| +0.1% | +$549 | 0.02% | 292 |
|
|
2025
Q1 | $408K | Buy |
19,231
+35
| +0.2% | +$742 | 0.03% | 281 |
|
|
2024
Q4 | $413K | Buy |
19,196
+54
| +0.3% | +$1.16K | 0.03% | 252 |
|
|
2024
Q3 | $455K | Buy |
19,142
+72
| +0.4% | +$1.71K | 0.03% | 236 |
|
|
2024
Q2 | $434K | Buy |
19,070
+42
| +0.2% | +$956 | 0.03% | 237 |
|
|
2024
Q1 | $422K | Buy |
19,028
+38
| +0.2% | +$843 | 0.03% | 260 |
|
|
2023
Q4 | $416K | Buy |
18,990
+46
| +0.2% | +$1.01K | 0.03% | 272 |
|
|
2023
Q3 | $375K | Buy |
18,944
+39
| +0.2% | +$773 | 0.04% | 275 |
|
|
2023
Q2 | $386K | Buy |
18,905
+42
| +0.2% | +$858 | 0.03% | 326 |
|
|
2023
Q1 | $390K | Buy |
18,863
+35
| +0.2% | +$724 | 0.03% | 310 |
|
|
2022
Q4 | $397K | Buy |
18,828
+38
| +0.2% | +$801 | 0.04% | 303 |
|
|
2022
Q3 | $356K | Buy |
18,790
+38
| +0.2% | +$720 | 0.04% | 294 |
|
|
2022
Q2 | $353K | Hold |
18,752
| – | – | 0.04% | 284 |
|
|
2022
Q1 | $445K | Hold |
18,752
| – | – | 0.04% | 262 |
|
|
2021
Q4 | $445K | Hold |
18,752
| – | – | 0.04% | 262 |
|
|
2021
Q3 | $480K | Buy |
+18,752
| New | +$480K | 0.04% | 218 |
|